Neuromedin U elicits cytokine release in murine Th2-type T cell clone D10.G4.1

Journal of Immunology

Volumn 173, Issue 12, 2004, Pages 7230-7238

  Johnson, Eric N ^a   Appelbaum, Edward R ^a   Carptenter, Donald C ^a   Cox, Richard F ^a   Disa, Jyoti ^a   Foley, James J ^a   Ghosh, Sujoy K ^a   Naselsky, Diane P ^a   Pullen, Mark A ^a   Sarau, Henry M ^a   Scheff, Samuel R ^a   Steplewski, Klaudia M ^a   Zaks Zilberman, Meirav ^a   Aiyar, Nambi ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALCIUM ION; CYTOKINE; DNA; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; IODINE 125; MESSENGER RNA; NEUROMEDIN U; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TH2 CELL;

EID: 10344225084     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.12.7230     Document Type: Article

References (43)

1. O'Garra, A., and N. Arai. 2000. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. 10:542.
2. Busse, W. W., and R. F. Lemanske, Jr. 2001. Asthma. N. Engl. J. Med. 344:350.
3. Levite, M. 1998. Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc. Natl. Acad. Sci. USA 95:12544.
4. Fried, M. 2003. Neuroimmunology and inflammation: implications for therapy of allergic and autoimmune diseases. Ann. Allergy Asthma Immunol. 90:34.
5. Domin, J., M. A. Ghatei, P. Chohan, and S. R. Bloom. 1987. Neuromedin U - a study of its distribution in the rat. Peptides 8:779.
6. Minamino, N., K. Kangawa, and H. Matsuo. 1985. Neuromedin U-8 and U-25: novel uterus stimulating and hypertensive peptides identified in porcine spinal cord. Biochem. Biophys. Res. Commun. 130:1078.
7. Minamino, N., T. Sudoh, K. Kangawa, and H. Matsuo. 1985. Neuromedins: novel smooth-muscle stimulating peptides identified in porcine spinal cord. Peptides 6(Suppl 3):245.
8. Maggi, C. A., R. Patacchini, S. Giuliani, D. Turini, G. Barbanti, P. Rovero, and A. Meli. 1990. Motor response of the human isolated small intestine and urinary bladder to porcine neuromedin U-8. Br. J. Pharmacol. 99:186.
9. Westfall, T. D., G. P. McCafferty, M. Pullen, S. Graver, A. C. Sulpizío, V. N. Aiyar, J. Disa, L. C. Contino, I. J. Mannan, and J. P. Hieble. 2002. Characterization of neuromedin U effects in canine smooth muscle. J. Pharmacol. Exp. Ther. 301:987.
10. Howard, A. D., R. Wang, S. S. Pong, T. N. Mellin, A. Strack, X. M. Guan, Z. Zeng, D. L. Williams, Jr., S. D. Feighner, C. N. Nunes, et al. 2000. Identification of receptors for neuromedin U and its role in feeding. Nature 406:70.
11. Nakazato, M., R. Hanada, N. Murakami, Y. Date, M. S. Mondal, M. Kojima, H. Yoshimatsu, K. Kangawa, and S. Matsukura. 2000. Central effects of neuromedin in the regulation of energy homeostasis. Biochem. Biophys. Res. Commun. 277:191.
12. Ivanov, T. R., C. B. Lawrence, P. J. Stanley, and S. M. Luckman. 2002. Evaluation of neuromedin U actions in energy homeostasis and pituitary function. Endocrinology 143:3813.
13. Wren, A. M., C. J. Small, C. R. Abbott, P. H. Jethwa, A. R. Kennedy, K. G. Murphy, S. A. Stanley, A. N. Zollner, M. A. Ghatei, and S. R. Bloom. 2002. Hypothalamic actions of neuromedin U. Endocrinology 143:4227.
14. Chu, C., Q. Jin, T. Kunitake, K. Kato, T. Nabekura, M. Nakazato, K. Kangawa, and H. Kannan. 2002. Cardiovascular actions of central neuromedin U in conscious rats. Regul. Pept. 105:29.
15. Tsubota, Y., N. Kakimoto, K. Owada-Makabe, K. Yukawa, X. M. Liang, M. Mune, and M. Maeda. 2003. Hypotensive effects of neuromedin U microinjected into the cardiovascular-related region of the rat nucleus tractus solitarius. NeuroReport 14:2387.
16. Cao, C. Q., X. H. Yu, A. Dray, A. Filosa, and M. N. Perkins. 2003. A pronociceptive role of neuromedin U in adult mice. Pain 104:609.
17. Yu, X. H., C. Q. Cao, F. Mennicken, C. Puma, A. Dray, D. O'Donnell, S. Ahmad, and M. Perkins. 2003. Pro-nociceptive effects of neuromedin U in rat. Neuroscience 120:467.
18. Hedrick, J. A., K. Morse, L. Shan, X. Qiao, L. Pang, S. Wang, T. Laz, E. L. Gustafson, M. Bayne, and F. J. Monsma, Jr. 2000. Identification of a human gastrointestinal tract and immune system receptor for the peptide neuromedin U. Mol. Pharmacol. 58:870.
19. Raddatz, R., A. E. Wilson, R. Artymyshyn, J. A. Bonini, B. Borowsky, L. W. Boteju, S. Zhou, E. V. Kouranova, R. Nagorny, M. S. Guevarra, et al. 2000. Identification and characterization of two neuromedin U receptors differentially expressed in peripheral tissues and the central nervous system. J. Biol. Chem. 275:32452.
20. Fujii, R., M. Hosoya, S. Fukusumi, Y. Kawamata, Y. Habata, S. Hinuma, H. Onda, O. Nishimura, and M. Fujino. 2000. Identification of neuromedin U as the cognate ligand of the orphan G protein-coupled receptor FM-3. J. Biol. Chem. 275:21068.
21. Siekeres, P. G., A. I. Muir, L. D. Spinage, J. E. Miller, S. I. Butler, A. Smith, G. I. Rennie, P. R. Murdock, L. R. Fitzgerald, H. Wu, et al. 2000. Neuromedin U is a potent agonist at the orphan G protein-coupled receptor FM3. J. Biol. Chem. 275:20247.
22. Kojima, M., R. Haruno, M. Nakazato, Y. Date, N. Murakami, R. Hanada, H. Matsuo, and K. Kangawa. 2000. Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3). Biochem. Biophys. Res. Commun. 276:435.
23. Funes, S., J. A. Hedrick, S. Yang, L. Shan, M. Bayne, F. J. Monsma, Jr., and E. L. Gustafson. 2002. Cloning and characterization of murine neuromedin U receptors. Peptides 23:1607.
24. Tan, C. P., K. K. McKee, Q. Liu, O. C. Palyha, S. D. Feighner, D. L. Hreniuk, R. G. Smith, and A. D. Howard. 1998. Cloning and characterization of a human and murine T-cell orphan G-protein-coupled receptor similar to the growth hormone secretagogue and neurotensin receptors. Genomics 52:223.
25. Hosoya, M., T. Moriya, Y. Kawamata, S. Ohkubo, R. Fujii, H. Matsui, Y. Shintani, S. Fukusumi, Y. Habata, S. Hinuma, et al. 2000. Identification and functional characterization of a novel subtype of neuromedin U receptor. J. Biol. Chem. 275:29528.
26. Sarau, H. M., J. J. Foley, D. B. Schmidt, L. D. Martin, E. F. Webb, M. N. Tzimas, J. J. Breton, M. Chabot-Fletcher, D. C. Underwood, D. W. Hay, et al. 1999. In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity. Prostaglandins Leukotrienes Essent. Fatty Acids. 61:55.
27. Crabtree, G. R., and E. N. Olson. 2002. NFAT signaling: choreographing the social lives of cells. Cell 109(Suppl.):S67.
28. Okkenhaug, K., and B. Vanhaesebroeck. 2003. PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 3:317.
29. DeSilva, D. R., E. A. Jones, M. F. Favata, B. D. Jaffee, R. L. Magolda, J. M. Trzaskos, and P. A. Scherle. 1998. Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy. J. Immunol. 160:4175.
30. Bootman, M. D., T. J. Collins, C. M. Peppiatt, L. S. Prothero, L. MacKenzie, P. De Smet, M. Travers, S. C. Tovey, J. T. Seo, M. J. Berridge, et al. 2001. Calcium signalling-an overview. Semin. Cell Dev. Biol. 12:3.
31. Clipstone, N. A., and G. R. Crabtree. 1992. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357:695.
32. Rao, A., C. Luo, and P. G. Hogan. 1997. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15:707.
33. Matsuda, S., and S. Koyasu. 2000. Mechanisms of action of cyclosporine. Immunopharmacology. 47:119.
34. Kelly-Welch, A. E., E. M. Hanson, M. R. Boothby, and A. D. Keegan. 2003. Interleukin-4 and interleukin-13 signaling connections maps. Science 300:1527.
35. Wang, L. H., R. A. Kirken, X. Y. Yang, R. A. Erwin, L. DaSilva, C. R. Yu, and W. L. Farrar. 2000. Selective disruption of interleukin 4 autocrine-regulated loop by a tyrosine kinase inhibitor restricts activity of T-helper 2 cells. Blood 95:3816.
36. Rincon, M. 2001. MAP-kinase signaling pathways in T cells. Curr. Opin. Immunol. 13:339.
37. Franklin, R. A., A. Tordai, H. Patel, A. M. Gardner, G. L. Johnson, and E. W. Gelfand. 1994. Ligation of the T cell receptor complex results in activation of the Ras/Raf-1/MEK/MAPK cascade in human T lymphocytes. J. Clin. Invest. 93:2134.
38. Yamashita, M., M. Kimura, M. Kubo, C. Shimizu, T. Tada, R. M. Perlmutter, and T. Nakayama. 1999. T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. Proc. Natl. Acad. Sci. USA 96:1024.
39. Egerton, M., D. R. Fitzpatrick, and A. Kelso. 1998. Activation of the extracellular signal-regulated kinase pathway is differentially required for TCR-stimulated production of six cytokines in primary T lymphocytes. Int. Immunol. 10:223.
40. Sasaki, T., J. Irie-Sasaki, R. G. Jones, A. J. Oliveira-dos-Santos, W. L. Stanford, B. Bolon, A. Wakeham, A. Itie, D. Bouchard, I. Kozieradzki, et al. 2000. Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration. Science 287:1040.
41. Macian, F., C. Lopez-Rodriguez, and A. Rao. 2001. Partners in transcription: NFAT and AP-1. Oncogene 20:2476.
42. Ebinu, J. O., S. L. Stang, C. Teixeira, D. A. Bottorff, J. Hooton, P. M. Blumberg, M. Barry, R. C. Bleakley, H. L. Ostergaard, and J. C. Stone. 2000. RasGRP links T-cell receptor signaling to Ras. Blood 95:3199.
43. Delgado, A. V., A. T. McManus, and J. P. Chambers. 2003. Production of tumor necrosis factor-α, interleukin 1-β, interleukin 2, and interleukin 6 by rat leukocyte subpopulations after exposure to substance P. Neuropeptides 37:355.